Biotricity Inc. (BTCY) vs IRIDEX Corporation (IRIX)

Biotricity Inc. and IRIDEX Corporation are both Medical Devices companies. Biotricity Inc. and IRIDEX Corporation are of similar size ($11.1M and $10.9M). Biotricity Inc. grew revenue faster over the last twelve months: 13.4% against 3.68%. IRIDEX Corporation has the higher net margin (−6.88% vs −21.0%) and the lower return on invested capital (−63.1% vs 0.00%). Across the 17 metrics below, Biotricity Inc. leads on 10 and IRIDEX Corporation on 7.

Valuation

Metric BTCY IRIX Medical Devices median
P/E n/m n/m 22.18
P/S 0.10 0.21 2.70
P/B n/m n/m 2.46
Price to free cash flow 12.27 n/m 22.53
EV/EBITDA 11.70 n/m 11.78
EV/Sales 1.70 0.23 2.38
Earnings yield (200.00%) (31.75%) (8.22%)
Free cash flow yield 8.15% (18.23%) (7.80%)

Profitability

Metric BTCY IRIX Medical Devices median
Gross margin 81.47% 35.92% 56.01%
Operating margin 9.56% (5.39%) (15.03%)
Net margin (21.00%) (6.88%) (20.40%)
Free cash flow margin 0.99% (3.88%) (7.24%)
Return on equity 9.75% 308.17% (15.32%)
Return on assets (57.12%) (12.06%) (19.72%)
Return on invested capital 0.00% (63.07%) (10.33%)

Growth

Metric BTCY IRIX Medical Devices median
Revenue growth (TTM) 13.41% 3.68% 8.80%
EPS growth (last fiscal year) 80.00% 51.85% —
Revenue growth, 5-year CAGR 36.43% 7.70% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BTCY IRIX Medical Devices median
Debt to equity (0.75) 1.04 0.07
Current ratio 0.15 1.82 2.50
Net debt to EBITDA 10.85 2.68 0.49

Dividend

Metric BTCY IRIX Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric BTCY IRIX Medical Devices median
Market cap 10.87m 11.07m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack